Markesh Manocha, MD
Ophthalmology · Savannah, GANPI 1396744181
Payments from drug & device makers
Across 596 payments — averaging $105.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$47K
- Alcon$3K
- AbbVie$2K
- Johnson & Johnson Surgical Vision, Inc.$2K
- Glaukos Corporation$2K
- NEW World Medical,inc.$1K
- plus $6K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 173 | $47,043 |
| Alcon | 63 | $3,022 |
| AbbVie(2 entities) | 82 | $1,876 |
| Johnson & Johnson Surgical Vision, Inc. | 32 | $1,547 |
| Glaukos Corporation | 23 | $1,519 |
| NEW World Medical,inc. | 46 | $1,472 |
| Rxsight Inc | 10 | $992 |
| Bausch & Lomb Americas Inc. | 21 | $964 |
| Oyster Point Pharma, Inc. | 21 | $560 |
| Mallinckrodt Hospital Products Inc. | 13 | $526 |
| Biotissue Holdings Inc. | 9 | $504 |
| Novartis | 16 | $458 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $419 |
| Aerie Pharmaceuticals, Inc. | 11 | $372 |
| Sight Sciences, Inc. | 17 | $357 |
| Kala Pharmaceuticals, Inc. | 9 | $279 |
| Tarsus Pharmaceuticals, Inc. | 5 | $180 |
| Eyevance Pharmaceuticals LLC | 3 | $157 |
| Rayner Intraocular Lenses Limited | 3 | $145 |
| Dompe US, Inc. | 5 | $117 |
| Shire North American Group Inc | 6 | $94 |
| Harrow Eye, LLC | 4 | $84 |
| Carl Zeiss Meditec, Inc. | 1 | $65 |
| Thea Pharma Inc. | 3 | $62 |
| Ocular Therapeutix, Inc. | 2 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Omeros Corporation | 1 | $18 |
| Eyepoint US, Inc. | 1 | $17 |
How this compares
$62,922 in reported general payments places this provider in the 90th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Savannah
- Eugene McLaurinSavannah$3.3M
- Robert KingSavannah$46K
- Thomas KandlSavannah$26K
- Dennis MarcusAugusta$9.2M
- Robert StoltzMarietta$3.9M
- Clayton BlehmGainesville$1.7M
- Lakshmana KooragayalaMarietta$1.4M
- Douglas DayAtlanta$1.1M
- Jennifer KimMorrow$989K
- Thomas AabergAtlanta$959K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.